5th Nordic RWE and AI conference
5th Nordic RWE and AI conference, 28-29 January 2025, Helsinki is organized by University of Helsinki and Åbo Akademi University. This conference is supported by NordicPOP, NordicPharmaTrain and European Federation for Pharmaceutical Industries and Associations Efpia. The Company sponsors listed in the Program have enabled us to organize the Event free of charge on Site and the City of Helsinki enables a nice Networking Event in the Evening. A warm thank you to all.
The event is organised by Mia Bengtström.
Program
5th Nordic RWE and AI conference: How will broad use of RWD and AI change Drug discovery and development and will the use of data improve the competitiveness of EU and result in value based decision making and healthcare?
12.00 Registration, networking and exhibition
12.50 Welcome and practicalities, Mia Bengtström Lecturer, University of Helsinki and Associate professor, Åbo Akademi University
13.00 Using RWE and AI in the development of Personalized Medicine to solve patient’s unmet medical needs and improving the competitiveness of EU, Anders Rething Borglykke, Vice President, Real World Evidence, Novo Nordisk A/S
13.25 EMA vision on the use of RWD and AI , Peter Arlett TBC
Implementation of EHDS – how to improve the competitiveness of the Nordic Region by using the excellent RWD assets
13.50 TEHDAS2 and VALO Value from Nordic health data – VALO – Sitra Markus Kalliola, Program Director, Coordinator of Joint Action Towards TEHDAS 2 and VALO projects
14.15 European Health Data Space – a stealth revolution. Richard Bergström, Vice President European Affairs, IQVIA
14.40 TBC
15.05- 15.35 Coffee, exhibition and networking.
Use of RWD and AI towards value based decision making and healthcare
15.35 The global value of Nordic data – selected use cases. Emilie Toresson Grip, Director, Head of RWE and Analytics, Quantify Research
15.55 Secure Processing Environment (SPE) – Your Gateway from Individual Level RWD to RWE. Erkki Soini. CEO, ESiOR Oy. Chairman on the Board, Kuopio Health
16.15 Nordic data landscape today and tomorrow, Riikka-Leena Leskelä, Research Director and Senior Partner at Nordic Healthcare Group
16.35 Use of RWD/RWE in medicines development and regulatory decision making, Sini Eskola, PhD Candidate at University of Utrecht and WHO Centre for Pharmaceutical Policy and Regulation; Director, Regulatory Strategy, EFPIA
16.55 Using Federated Data Networks and Common Data Models for Health Technology Assessment. Ravinder Claire, Scientific Adviser – Science Policy and Research Programme, National Institute for Health and Care Excellence
17.20 Comparative effectiveness of first line pembrolizumab vs. chemotherapy in advanced non-small cell Lung-cancer after approval and reimbursement: A Norwegian Population-Based Cohort Study. Simon Boge Brant, PhD, NordicRWE
17.40 Thank you for the Day and walking to the City Hall
18.00- 19.30 The Networking Reception
Day 2
Chairs: Martta Ranta, Head of Medical Research, Abbvie and Juha Laine, Nordic HEOR Manager and RWD Advisor, Roche
Use of RWD and AI towards value based decision making and healthcare
9.00 Value based healthcare, Irene Eriksson, EMEA Partnership Lead, J&J
9.25 Building a Foundation for Evidence-Based Healthcare: The Impact of Real-Time Data in clinical decision making, Real-World Evidence Generation and on building Registries. Joakim Söderberg, Head of Business Development, BCB Medical
9.45 Use of natural language processing and machine learning to extract smoking status from patient texts in Finnish data lakes: lung cancer outcomes related to smoking as case example, Olivia Hölsä, Data Scientist, Medaffcon Oy
10.00 Why does the Nordics exceed in RWE – or could we do better?
Real-time hospital-level clinical cost-effectiveness RWD production and reporting at HUS/HUCH. Sami Pakarinen, Chief Medical Officer of Clinical Auditing (deputy) at HUS/HUCH
EU Case: IHI Prominent, digital platform for precision medicine, Linus Jönsson, Professor, Karolinska Institute
Fireside discussion with Sami Pakarinen and Linus Jönsson moderated by Lisse-Lotte Hermansson, Country Director Medaffcon AB
10.40 Networking break
11.00 Real4Reg – Unlocking Real-World Data with AI, Anna-Maija Tolppanen, Professor, University of Easten Finland
11.25 The Power of Next-Gen Anonymization: Secure, Compliant, and Accessible Data, Tuomo Pentikäinen, CEO, VEIL.AI
11.45 HealthHub Finland EDIH – Auria Clinical Informatics – Agile Path for RWD Research. Arho Virkki, Chief Analytics Officer, Wellbeing Services County of South-West Finland (Varha)
12.05 Real World Evidence Reveal Unjustified Antibiotic Use for the treatment of acne, Johanna Vinblad, Manager HEOR, Market Access & Healthcare Consulting, PharmaLex (part of Cencora)
12.30-13.30 Lunch
Use of RWD and AI in Drug discovery and development
13.30 Transforming drug development in the future using Large Scale Data to find novel treatments for under-studied medical needs, William Hennah, Senior Scientist Genomics at Orion Pharma Oy
13.55 The power of combining Norwegian Healthdata and AI: A case example from Novartis and Akershus University Hospital, Novartis
14.30 Transforming Clinical Trial Practices through Real-World Data. Tero Ylisaukko-oja, CEO, founder, MedEngine Oy
14.50 TBC
15.15 TBC
15.25-15.30 Thank you for participating and funding, Mia Bengtström
